Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05625191 · ClinicalTrials.gov registry record

Patients With and Without Phonotrauma

A clinical trial of Phonotrauma, sponsored by University of Texas Southwestern Medical Center.

Recruiting
Registry status
100
Enrollment target
1
Study location

NCT05625191: Recruiting study of Phonotrauma, sponsored by University of Texas Southwestern Medical Center.

NCT05625191 is a study of Phonotrauma that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05625191, a study of Phonotrauma, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.

RECRUITING
Registry status
100 participants
Enrollment target
1
Study location

Study Summary

There is a substantial need to identify objective measures associated with hyperadduction of the vocal folds to recognize those at higher risk of developing phonotrauma so that risk mitigation strategies can be implemented before phonotrauma develops. The overall objective of this proposed project is to investigate the sensitivity and direction of change in cepstral peak prominence (CPP) and the magnitude difference between the first two harmonics of the voice spectrum (H1-H2) in response to varied phonation patterns, which will be addressed using the following two aims: Aim 1: Determine how CPP and H1-H2 change as a function of using pressed voice production in individuals without laryngeal pathology. Aim 2: Examine the sensitivity (minimally detectable change) and responsiveness (minimal clinically important difference) of CPP and H1-H2 to detect changes in different voice production conditions.

Primary Outcome

Cepstral peak prominence is a measure of the periodic energy of the acoustic voice signal.

Conditions Studied

Interventions

  • DIAGNOSTIC_TEST Acoustic voice analysis
  • DIAGNOSTIC_TEST High-speed videoendoscopy

Study Locations (1)

Texas

  • UT Southwestern Medical Center - Dallas

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2023-01-17
Est. Completion 2025-12-30

What NCT05625191 shows while recruiting

NCT05625191 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.

The record links to 1 condition, with Phonotrauma appearing as the primary indexed condition, and to 2 interventions - of which Acoustic voice analysis is the first listed.

NCT05625191 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT05625191 about?

NCT05625191 is a clinical study titled "Patients With and Without Phonotrauma". There is a substantial need to identify objective measures associated with hyperadduction of the vocal folds to recognize those at higher risk of developing phonotrauma so that risk mitigation strategies can be implemented before phonotrauma develops. The overall objective of this proposed project i...

What is the current status of trial NCT05625191?

This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2023-01-17. Estimated completion is 2025-12-30.

What conditions does trial NCT05625191 study?

This clinical trial studies the following conditions: Phonotrauma.

What interventions are being tested in trial NCT05625191?

The interventions under investigation include: Acoustic voice analysis (DIAGNOSTIC_TEST), High-speed videoendoscopy (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT05625191?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05625191 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05625191, the US trial registry maintained by the National Library of Medicine. NCT05625191 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.